Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population

Brain, Behavior, and Immunity

Volumn 65, Issue , 2017, Pages 150-160

  Gu, Yian ^a   Vorburger, Robert ^b   Scarmeas, Nikolaos ^a,c,d   Luchsinger, José A ^a,e,f   Manly, Jennifer J ^a,c   Schupf, Nicole ^a,f   Mayeux, Richard ^a,c,f   Brickman, Adam M ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d UNIVERSITY OF ATHENS   (Greece)

^e NONE   (United States)

^f NONE   (United States)

Author keywords

Alpha 1 antichymotrypsin; Brain atrophy; Brain morphometry; C reactive protein; Cortical thickness; Interleukin 6; Magnetic resonance imaging; Neuroepidemiology

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; INTERLEUKIN 6; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

AGE; AGED; APOE GENE; ARTICLE; BODY MASS; BRAIN SIZE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DEMENTIA; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL CORTEX; GENDER; GENOTYPE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; SMOKING; TEMPORAL CORTEX; THALAMUS; VERY ELDERLY; WHITE MATTER; ANATOMY AND HISTOLOGY; ATROPHY; BLOOD; BRAIN; COHORT ANALYSIS; DIFFUSION TENSOR IMAGING; IMMUNOLOGY; LONGITUDINAL STUDY; METABOLISM; NORMAL HUMAN; PATHOLOGY; PROCEDURES;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ATROPHY; BIOMARKERS; BRAIN; C-REACTIVE PROTEIN; COHORT STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; WHITE MATTER;

EID: 85018438044     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.04.022     Document Type: Article

References (84)

1. Abraham, C.R., Shirahama, T., Potter, H., Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol. Aging 11:2 (1990), 123–129.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., 1987, American Psychiatric Press, Washington, DC.
3. Arfanakis, K., Fleischman, D.A., Grisot, G., Barth, C.M., Varentsova, A., Morris, M.C., et al. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS ONE, 8(8), 2013, e73107.
4. Balschun, D., Wetzel, W., Del Rey, A., Pitossi, F., Schneider, H., Zuschratter, W., et al. Interleukin-6: a cytokine to forget. FASEB J. 18:14 (2004), 1788–1790.
5. Baune, B.T., Ponath, G., Rothermundt, M., Roesler, A., Berger, K., Association between cytokines and cerebral MRI changes in the aging brain. J. Geriatr. Psychiatry Neurol. 22:1 (2009), 23–34.
6. Bettcher, B.M., Wilheim, R., Rigby, T., Green, R., Miller, J.W., Racine, C.A., et al. C-reactive protein is related to memory and medial temporal brain volume in older adults. Brain Behav. Immun. 26:1 (2012), 103–108.
7. Blasko, I., Apochal, A., Boeck, G., Hartmann, T., Grubeck-Loebenstein, B., Ransmayr, G., Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol. Dis. 8:6 (2001), 1094–1101.
8. Brickman, A.M., Schupf, N., Manly, J.J., Luchsinger, J.A., Andrews, H., Tang, M.X., et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch. Neurol. 65:8 (2008), 1053–1061.
9. Dale, A.M., Optimal experimental design for event-related fMRI. Hum. Brain Mapp. 8:2–3 (1999), 109–114.
10. De Simoni, M.G., De Luigi, A., Gemma, L., Sironi, M., Manfridi, A., Ghezzi, P., Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265:4 Pt 2 (1993), R739–R742.
11. Devanand, D.P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68:11 (2007), 828–836.
12. Dickerson, B.C., Bakkour, A., Salat, D.H., Feczko, E., Pacheco, J., Greve, D.N., et al. The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 19:3 (2009), 497–510.
13. Dik, M.G., Jonker, C., Hack, C.E., Smit, J.H., Comijs, H.C., Eikelenboom, P., Serum inflammatory proteins and cognitive decline in older persons. Neurology 64:8 (2005), 1371–1377.
14. Dlugaj, M., Gerwig, M., Wege, N., Siegrist, J., Mann, K., Brocker-Preuss, M., et al. Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study. J. Alzheimer's Dis.: JAD 28:3 (2012), 503–514.
15. Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72:22 (2009), 1906–1913.
16. Economos, A., Wright, C.B., Moon, Y.P., Rundek, T., Rabbani, L., Paik, M.C., et al. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study. Neuroepidemiology 40:4 (2013), 253–259.
17. Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J.C., et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 61:5 (2004), 668–672.
18. Eriksson, U.K., Pedersen, N.L., Reynolds, C.A., Hong, M.G., Prince, J.A., Gatz, M., et al. Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer's disease and dementia. J. Alzheimer's Dis.: JAD 23:2 (2011), 361–369.
19. Fischl, B., Dale, A.M., Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U.S.A. 97:20 (2000), 11050–11055.
20. Fischl, B., Salat, D.H., van der Kouwe, A.J., Makris, N., Segonne, F., Quinn, B.T., et al. Sequence-independent segmentation of magnetic resonance images. NeuroImage 23:Suppl 1 (2004), S69–S84.
21. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000), 244–254.
22. Frodl, T., Amico, F., Is there an association between peripheral immune markers and structural/functional neuroimaging findings?. Prog. Neuropsychopharmacol. Biol. Psychiatry 48 (2014), 295–303.
23. Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42:9 (2011), 2672–2713.
24. Gu, Y., Zeleniuch-Jacquotte, A., Linkov, F., Koenig, K.L., Liu, M., Velikokhatnaya, L., et al. Reproducibility of serum cytokines and growth factors. Cytokine 45:1 (2009), 44–49.
25. Gu, Y., Brickman, A.M., Stern, Y., Habeck, C.G., Razlighi, Q.R., Luchsinger, J.A., et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology 85:20 (2015), 1744–1751.
26. Gu, Y., Vorburger, R.S., Gazes, Y., Habeck, C.G., Stern, Y., Luchsinger, J.A., et al. White matter integrity as a mediator in the relationship between dietary nutrients and cognition in the elderly. Ann. Neurol. 79:6 (2016), 1014–1025.
27. Gunstad, J., Bausserman, L., Paul, R.H., Tate, D.F., Hoth, K., Poppas, A., et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J. Clin. Neurosci. 13:5 (2006), 540–546.
28. Hedman, A.M., van Haren, N.E., Schnack, H.G., Kahn, R.S., Hulshoff Pol, H.E., Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum. Brain Mapp. 33:8 (2012), 1987–2002.
29. Hixson, J.E., Vernier, D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:3 (1990), 545–548.
30. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9:1 (2010), 119–128.
31. Jaeger, L.B., Dohgu, S., Sultana, R., Lynch, J.L., Owen, J.B., Erickson, M.A., et al. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun. 23:4 (2009), 507–517.
32. Jefferson, A.L., Massaro, J.M., Wolf, P.A., Seshadri, S., Au, R., Vasan, R.S., et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 68:13 (2007), 1032–1038.
33. Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A.L., Yaffe, K., The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 68:4 (2013), 433–440.
34. Lerch, J.P., Pruessner, J., Zijdenbos, A.P., Collins, D.L., Teipel, S.J., Hampel, H., et al. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol. Aging 29:1 (2008), 23–30.
35. Licastro, F., Parnetti, L., Morini, M.C., Davis, L.J., Cucinotta, D., Gaiti, A., et al. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9:2 (1995), 112–118.
36. Manly, J.J., Bell-McGinty, S., Tang, M.X., Schupf, N., Stern, Y., Mayeux, R., Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch. Neurol. 62:11 (2005), 1739–1746.
37. Marsland, A.L., Gianaros, P.J., Abramowitch, S.M., Manuck, S.B., Hariri, A.R., Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 64:6 (2008), 484–490.
38. Marsland, A.L., Gianaros, P.J., Kuan, D.C., Sheu, L.K., Krajina, K., Manuck, S.B., Brain morphology links systemic inflammation to cognitive function in midlife adults. Brain Behav. Immun. 48 (2015), 195–204.
39. Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., et al. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28:4 (1990), 561–567.
40. McCarrey, A.C., Pacheco, J., Carlson, O.D., Egan, J.M., Thambisetty, M., An, Y., et al. Interleukin-6 is linked to longitudinal rates of cortical thinning in aging. Transl. Neurosci. 5:1 (2014), 1–7.
41. McCarty, M.F., Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses 52:5 (1999), 465–477.
42. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:7 (1984), 939–944.
43. Miralbell, J., Soriano, J.J., Spulber, G., Lopez-Cancio, E., Arenillas, J.F., Bargallo, N., et al. Structural brain changes and cognition in relation to markers of vascular dysfunction. Neurobiol. Aging 33:5 (2012), 1003.e9–1003.e17.
44. Monje, M.L., Toda, H., Palmer, T.D., Inflammatory blockade restores adult hippocampal neurogenesis. Science (New York, NY) 302:5651 (2003), 1760–1765.
45. Mooijaart, S.P., Sattar, N., Trompet, S., Lucke, J., Stott, D.J., Ford, I., et al. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J. Intern. Med. 274:1 (2013), 77–85.
46. Mori, S., Oishi, K., Jiang, H., Jiang, L., Li, X., Akhter, K., et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. NeuroImage 40:2 (2008), 570–582.
47. Noble, J.M., Manly, J.J., Schupf, N., Tang, M.X., Mayeux, R., Luchsinger, J.A., Association of C-reactive protein with cognitive impairment. Arch. Neurol. 67:1 (2010), 87–92.
48. Palta, P., Xue, Q.L., Deal, J.A., Fried, L.P., Walston, J.D., Carlson, M.C., Interleukin-6 and C-reactive protein levels and 9-year cognitive decline in community-dwelling older women: the Women's Health and Aging Study II. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 70:7 (2015), 873–878.
49. Pavlov, V.A., Parrish, W.R., Rosas-Ballina, M., Ochani, M., Puerta, M., Ochani, K., et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23:1 (2009), 41–45.
50. Perry, V.H., Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 120:3 (2010), 277–286.
51. Petersen, R.C., Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256:3 (2004), 183–194.
52. Porcellini, E., Davis, E.J., Chiappelli, M., Ianni, E., Di Stefano, G., Forti, P., et al. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target. Curr. Pharm. Des. 14:26 (2008), 2659–2664.
53. Querbes, O., Aubry, F., Pariente, J., Lotterie, J.A., Demonet, J.F., Duret, V., et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 132:Pt 8 (2009), 2036–2047.
54. Raskin, J., Cummings, J., Hardy, J., Schuh, K., Dean, R.A., Neurobiology of Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr. Alzheimer Res. 12:8 (2015), 712–722.
55. Ravaglia, G., Forti, P., Maioli, F., Chiappelli, M., Montesi, F., Tumini, E., et al. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol. Aging 28:12 (2007), 1810–1820.
56. Reale, M., Greig, N.H., Kamal, M.A., Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev. Med. Chem. 9:10 (2009), 1229–1241.
57. Resnick, S.M., Pham, D.L., Kraut, M.A., Zonderman, A.B., Davatzikos, C., Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 23:8 (2003), 3295–3301.
58. Ridker, P.M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:3 (2003), 363–369.
59. Rosano, C., Aizenstein, H.J., Newman, A.B., Venkatraman, V., Harris, T., Ding, J., et al. Neuroimaging differences between older adults with maintained versus declining cognition over a 10-year period. NeuroImage 62:1 (2012), 307–313.
60. Satizabal, C.L., Zhu, Y.C., Mazoyer, B., Dufouil, C., Tzourio, C., Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 78:10 (2012), 720–727.
61. Schmidt, R., Schmidt, H., Curb, J.D., Masaki, K., White, L.R., Launer, L.J., Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 52:2 (2002), 168–174.
62. Schmidt, M.F., Freeman, K.B., Windham, B.G., Griswold, M.E., Kullo, I.J., Turner, S.T., et al. Associations between serum inflammatory markers and hippocampal volume in a community sample. J. Am. Geriatr. Soc. 64:9 (2016), 1823–1829.
63. Segonne, F., Dale, A.M., Busa, E., Glessner, M., Salat, D., Hahn, H.K., et al. A hybrid approach to the skull stripping problem in MRI. NeuroImage 22:3 (2004), 1060–1075.
64. Segonne, F., Pacheco, J., Fischl, B., Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans. Med. Imaging 26:4 (2007), 518–529.
65. Semmler, A., Okulla, T., Sastre, M., Dumitrescu-Ozimek, L., Heneka, M.T., Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J. Chem. Neuroanat. 30:2–3 (2005), 144–157.
66. Singh, T., Newman, A.B., Inflammatory markers in population studies of aging. Ageing Res. Rev. 10:3 (2011), 319–329.
67. Singh-Manoux, A., Dugravot, A., Brunner, E., Kumari, M., Shipley, M., Elbaz, A., et al. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 83:6 (2014), 486–493.
68. Sled, J.G., Zijdenbos, A.P., Evans, A.C., A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 17:1 (1998), 87–97.
69. Sochocka, M., Diniz, B.S., Leszek, J., Inflammatory response in the CNS: friend or foe?. Mol. Neurobiol., 2016.
70. Squire, L.R., Stark, C.E., Clark, R.E., The medial temporal lobe. Annu. Rev. Neurosci. 27 (2004), 279–306.
71. Stern, Y., Andrews, H., Pittman, J., Sano, M., Tatemichi, T., Lantigua, R., et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol. 49:5 (1992), 453–460.
72. Sun, Y.X., Minthon, L., Wallmark, A., Warkentin, S., Blennow, K., Janciauskiene, S., Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 16:3 (2003), 136–144.
73. Taki, Y., Thyreau, B., Kinomura, S., Sato, K., Goto, R., Wu, K., et al. Correlation between high-sensitivity C-reactive protein and brain gray matter volume in healthy elderly subjects. Hum. Brain Mapp. 34:10 (2013), 2418–2424.
74. Tan, Z.S., Beiser, A.S., Vasan, R.S., Roubenoff, R., Dinarello, C.A., Harris, T.B., et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68:22 (2007), 1902–1908.
75. Tancredi, V., D'Antuono, M., Cafe, C., Giovedi, S., Bue, M.C., D'Arcangelo, G., et al. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J. Neurochem. 75:2 (2000), 634–643.
76. Tang, M.X., Cross, P., Andrews, H., Jacobs, D.M., Small, S., Bell, K., et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56:1 (2001), 49–56.
77. van Himbergen, T.M., Beiser, A.S., Ai, M., Seshadri, S., Otokozawa, S., Au, R., et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch. Neurol. 69:5 (2012), 594–600.
78. Vernooij, M.W., Ikram, M.A., Vrooman, H.A., Wielopolski, P.A., Krestin, G.P., Hofman, A., et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch. Gen. Psychiatry 66:5 (2009), 545–553.
79. Weaver, J.D., Huang, M.H., Albert, M., Harris, T., Rowe, J.W., Seeman, T.E., Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:3 (2002), 371–378.
80. Wersching, H., Duning, T., Lohmann, H., Mohammadi, S., Stehling, C., Fobker, M., et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 74:13 (2010), 1022–1029.
81. Winkler, A.M., Kochunov, P., Blangero, J., Almasy, L., Zilles, K., Fox, P.T., et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. NeuroImage 53:3 (2010), 1135–1146.
82. Wyss-Coray, T., Rogers, J., Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Persp. Med., 2(1), 2012, a006346.
83. Yaffe, K., Lindquist, K., Penninx, B.W., Simonsick, E.M., Pahor, M., Kritchevsky, S., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61:1 (2003), 76–80.
84. Zhang, H., Sachdev, P.S., Wen, W., Crawford, J.D., Brodaty, H., Baune, B.T., et al. The relationship between inflammatory markers and voxel-based gray matter volumes in nondemented older adults. Neurobiol. Aging 37 (2016), 138–146.